Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
myeloid leukemia
Pharma
Novartis wins CML nod for new Gleevec follow-on Scemblix
Novartis’ oncology chief Susanne Schaffert, Ph.D., said Scemblix has blockbuster potential in third-line CML alone.
Angus Liu
Nov 1, 2021 6:51am
Takeda pads case for new leukemia use with 5-year survival data
Dec 8, 2020 8:35am
Astex's Inqovi nod gives patients on decitabine a non-IV option
Aug 3, 2020 8:00am
AZ's Calquence chases Imbruvica with phase 3 leukemia win
May 7, 2019 11:40am
